Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABVX Abivax S.A.

已收盘 05-29 16:00:00 EDT

132.63

+3.13

+2.42%

盘后133.48

+0.85+0.64%

19:54 EDT

最高133.50	最低127.89	成交量188.65万
今开130.61	昨收129.50	日振幅4.33%
总市值105.02亿	流通市值56.57亿	总股本7,919万
成交额2.48亿	换手率4.42%	流通股本4,266万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":132.63,"timestamp":1780084800000,"preClose":129.5,"halted":0,"volume":1886466,"hourTrading":{"tag":"盘后","latestPrice":133.479,"preClose":132.63,"latestTime":"19:54 EDT","volume":13986,"amount":1859180.7495,"timestamp":1780098859684,"change":0.849,"changeRate":0.006401,"amplitude":0.008746},"delay":0,"changeRate":0.024169884169884134,"floatShares":42655700,"shares":79185160,"eps":-5.216782,"marketStatus":"已收盘","change":3.13,"latestTime":"05-29 16:00:00 EDT","open":130.61,"high":133.5,"low":127.89,"amount":248386507.29558,"amplitude":0.04332,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.216782,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":5,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":129.5,"preHourTrading":{"tag":"盘前","latestPrice":130.62,"preClose":129.5,"latestTime":"09:29 EDT","volume":42896,"amount":5700545.527039999,"timestamp":1780061389896,"change":1.12,"changeRate":0.008649,"amplitude":0.030656},"postHourTrading":{"tag":"盘后","latestPrice":133.479,"preClose":132.63,"latestTime":"19:54 EDT","volume":13986,"amount":1859180.7495,"timestamp":1780098859684,"change":0.849,"changeRate":0.006401,"amplitude":0.008746},"volumeRatio":1.487707,"impliedVol":1.7773,"impliedVolPercentile":0.9828},"requestUrl":"/m/hq/s/ABVX/tweets","defaultTab":"tweets","newsList":[{"id":"1131761327","title":"异动解读｜Abivax S.A.盘中上涨5.03%，财报披露现金储备充裕提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1131761327","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131761327?lang=zh_cn&edition=full","pubTime":"2026-05-26 23:16","pubTimestamp":1779808609,"startTime":"0","endTime":"0","summary":"5月26日，Abivax S.A.盘中上涨5.03%，报128.12美元/股，成交额8500.7万美元。消息面上，公司披露截至3月31日持有现金、现金等价物及短期投资4.916亿欧元，基于当前运营假设预计现金跑道可延续至第四季度，资金面充裕缓解了市场对其研发可持续性的担忧。Abivax S.A.是一家临床阶段的生物技术公司，专注于开发利用人体自然调节机制来稳定慢性炎症性疾病免疫反应的疗法，其主要候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段，并正在开发用于克罗恩病。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155275439","title":"异动解读 | 现金储备充裕缓解研发担忧，Abivax S.A.盘前大涨8.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155275439","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155275439?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:14","pubTimestamp":1779783267,"startTime":"0","endTime":"0","summary":"生物技术公司Abivax S.A.（股票代码：ABVX）今日盘前股价大幅上涨8.26%，表现强劲。消息面上，公司近期披露的财务数据显示，截至3月31日，其持有的现金、现金等价物及短期投资总额达4.916亿欧元。基于当前的运营假设，公司预计其现金跑道可延续至今年第四季度。这一充裕的资金状况有效缓解了市场对其核心药物研发项目可持续性的担忧。此外，市场情绪受到机构看多观点的提振。多数卖方分析师维持对该股的买入评级，并给出了高于当前股价的目标价。市场普遍关注其融资与版税安排对长期现金流路径的积极影响，这共同构成了推动股价在盘前时段显著走高的主要因素。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143487991","title":"异动解读｜Abivax S.A.盘前上涨9.06%，财报披露现金储备充裕提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1143487991","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143487991?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:07","pubTimestamp":1779782858,"startTime":"0","endTime":"0","summary":"5月26日，Abivax S.A.盘前上涨9.06%，报130.46美元/股，成交额122.15万美元。消息面上，公司披露截至3月31日持有现金、现金等价物及短期投资4.916亿欧元，基于当前运营假设预计现金跑道可延续至第四季度，资金面充裕缓解了市场对其研发可持续性的担忧。Abivax S.A.是一家临床阶段的生物技术公司，专注于开发利用人体自然调节机制来稳定慢性炎症性疾病免疫反应的疗法，其主要候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段，并正在开发用于克罗恩病。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199128647","title":"异动解读 | 现金储备充裕缓解研发担忧，Abivax S.A.夜盘大涨9.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199128647","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199128647?lang=zh_cn&edition=full","pubTime":"2026-05-26 15:35","pubTimestamp":1779780949,"startTime":"0","endTime":"0","summary":"Abivax S.A.（股票代码：ABVX）今日夜盘股价大幅上涨9.85%，表现强劲。消息面上，公司近期披露的财务数据显示，截至3月31日，其持有的现金、现金等价物及短期投资总额达4.916亿欧元。基于当前的运营假设，公司预计其现金跑道可延续至今年第四季度。这一充裕的资金状况有效缓解了市场对其核心药物研发项目可持续性的担忧。此外，市场情绪受到机构看多观点的提振。多数卖方分析师维持对该股的买入评级，并给出了高于当前股价的目标价。市场普遍关注其融资与版税安排对长期现金流路径的积极影响，这共同构成了推动股价在夜盘时段显著走高的主要因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132190360","title":"异动解读｜Abivax S.A.夜盘上涨5.8%，财报披露现金储备充裕提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1132190360","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132190360?lang=zh_cn&edition=full","pubTime":"2026-05-26 08:21","pubTimestamp":1779754894,"startTime":"0","endTime":"0","summary":"5月26日，Abivax S.A.夜盘上涨5.8%，报129.06美元/股。消息面上，公司披露截至3月31日持有现金、现金等价物及短期投资4.916亿欧元，基于当前运营假设预计现金跑道可延续至第四季度，资金面充裕缓解了市场对其研发可持续性的担忧。Abivax Sa是一家临床阶段的生物技术公司，专注于开发利用人体自然调节机制来稳定慢性炎症性疾病免疫反应的疗法，其主要候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190413427","title":"异动解读｜Abivax S.A.盘中上涨5.09%，财报发布在即机构看多情绪占优","url":"https://stock-news.laohu8.com/highlight/detail?id=1190413427","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190413427?lang=zh_cn&edition=full","pubTime":"2026-05-22 02:27","pubTimestamp":1779388050,"startTime":"0","endTime":"0","summary":"5月22日，Abivax S.A.盘中上涨5.09%，报125.885美元/股，成交额9558.64万美元。消息面上，Abivax S.A.将于5月25日美股盘前发布财报，尽管本季度营收预计同比锐减88.78%，但从已披露的机构观点看，看多阵营占优，多数卖方对公司维持买入评级基调，并给出高于现价区间的目标价，市场聚焦其融资与版税安排对费用及现金流路径的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131176805","title":"异动解读｜Abivax S.A.盘中上涨5.18%，财报发布在即机构看多情绪占优","url":"https://stock-news.laohu8.com/highlight/detail?id=1131176805","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131176805?lang=zh_cn&edition=full","pubTime":"2026-05-20 23:35","pubTimestamp":1779291326,"startTime":"0","endTime":"0","summary":"5月20日，Abivax S.A.盘中上涨5.18%，报119.625美元/股，成交额7587.17万美元。消息面上，Abivax S.A.将于5月25日美股盘前发布财报，尽管本季度营收预计同比锐减88.78%，但从已披露的机构观点看，看多阵营占优，多数卖方对公司维持\"买入\"评级基调，并给出高于现价区间的目标价，市场聚焦其融资与版税安排对费用及现金流路径的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165708087","title":"财报前瞻 ｜Abivax S.A.本季度营收预计锐减88.78%，机构多头占优","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708087","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165708087?lang=zh_cn&edition=full","pubTime":"2026-05-18 08:02","pubTimestamp":1779062526,"startTime":"0","endTime":"0","summary":"Abivax S.A.将于2026年05月25日美股盘前发布财报，市场聚焦融资与版税安排对费用与现金流路径的影响。上季度Abivax S.A.营收为44.00万欧元，毛利率为100.00%，归属于母公司股东的净利润为-8,196.00万欧元，净利率未披露，调整后每股收益为-1.14欧元。从已披露的机构观点看，看多阵营占优，多数卖方对Abivax S.A.维持“买入”为主的评级基调，并给出高于现价区间的目标价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"财报前瞻 ｜Abivax S.A.本季度营收预计锐减88.78%，机构多头占优","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108202124","title":"财报前瞻｜Abivax S.A.本季度营收预计降29.21%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1108202124","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108202124?lang=zh_cn&edition=full","pubTime":"2026-03-16 10:07","pubTimestamp":1773626855,"startTime":"0","endTime":"0","summary":"Abivax S.A.将于2026年03月23日发布最新季度财报，市场关注公司现金消耗与管线推进的节奏，研发投入及利润指标或承压。市场一致预期显示，本季度Abivax S.A.营收预计为1,435,000.00欧元，同比下降29.21%；调整后每股收益预计为-1.28欧元，同比下降14.62%；息税前利润预计为-73,706,000.00欧元，同比下降67.79%。根据近期公开报道的分析师观点，围绕Abivax S.A.在研发阶段的现金消耗与管线推进，机构态度偏谨慎，认为在缺乏明确的商业化现金流前，季度亏损与每股亏损存在维持的可能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Abivax S.A.本季度营收预计降29.21%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605177593","title":"生物制药公司Abivax驳斥有关礼来收购的传言","url":"https://stock-news.laohu8.com/highlight/detail?id=2605177593","media":"格隆汇","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605177593?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:11","pubTimestamp":1768918273,"startTime":"0","endTime":"0","summary":"格隆汇1月20日｜法国生物制药公司Abivax首席执行官Marc de Garidel将法国媒体关于礼来可能收购Abivax的报道斥为“噪音”，并称市场关于法国当局正在进行审查的猜测不符合法国外商投资监管的运作方式。该公司在上周举行的摩根大通医疗保健会议期间会见了数十位潜在投资者。该公司称一直在寻找高质量的投资者来进一步增强股东基础，但关于“买家”，公司不对市场传言或猜测发表评论。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120221220a730f711&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120221220a730f711&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2168563687.JPY","LU0198837287.USD","LU1868836914.USD","LU1988902786.USD","LU0466842654.USD","LU0006306889.USD","IE00B1XK9C88.USD","LU0079474960.USD","GB00BDT5M118.USD","LU2211815571.USD","LU2265009873.SGD","LU2237443549.SGD","IE0002141913.USD","BK4516","LU1868836591.USD","LU0820561818.USD","LU1093756168.USD","LU0417517546.SGD","LU1366192091.USD","LU1983299246.USD","IE00B4R5TH58.HKD","LU0320765059.SGD","LU0823434740.USD","IE0009355771.USD","LU0943347566.SGD","LU0683600562.USD","LU0353189680.USD","LU0820561909.HKD","LU0823416689.USD","LU0266013472.USD","LU0456855351.SGD","LU1551013342.USD","SG9999015952.SGD","LU2750360641.GBP","LU2063271972.USD","LU2087625088.SGD","IE00BKDWB100.SGD","LU0787776722.HKD","LU0889565916.HKD","LU2361044865.SGD","LU2746668974.SGD","LU1232071149.USD","LU2236285917.USD","LU2552382132.HKD","LU0106261372.USD","LU0225283273.USD","SG9999017495.SGD","SG9999018865.SGD","SG9999015945.SGD","LU2461242641.AUD","LU0109391861.USD","LU2237443382.USD","LU2237443465.HKD","LU0353189763.USD","SGXZ31699556.SGD","LU1064131342.USD","LU2552382058.USD","LU0203202063.USD","LU1720051108.HKD","LU0354030438.USD","LU1057294990.SGD","LU0354030511.USD","IE00B2B36J28.USD","LU0323591593.USD","LU0786609619.USD","LU2750360997.AUD","LU0689472784.USD","SGXZ81514606.USD","LU2491050154.USD","LU2471134952.CNY","IE0005OL40V9.USD","LU0256863811.USD","BK4534","LU0320765992.SGD","LU2106854487.HKD","LU2168564222.USD","LU2237443978.SGD","LU0823434583.USD","LU2746668461.USD","LU1917777945.USD","BK4139","LU1023059063.AUD","SG9999014880.SGD","LU1093756325.SGD","LU1267930730.SGD","LU2360106947.USD","LU1548497426.USD","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU0096364046.USD","SG9999001176.SGD","LU2023250504.SGD","IE00B775H168.HKD","LU0061475181.USD","IE00B4JS1V06.HKD","LU0708995401.HKD","SGXZ57979304.SGD","BK4533","LU0058720904.USD","SGXZ99366536.SGD","IE00BN29S564.USD","LU0672654240.SGD","LU0114720955.EUR","LU1868836757.USD","LU1280957306.USD","LU1323610961.USD","SG9999001176.USD","IE0004445015.USD","LU1868837300.USD","IE00BFSS7M15.SGD","LU2361045086.USD","SGXZ51526630.SGD","IE0004445239.USD","LU0471298777.SGD","IE00BKPKM429.USD","LU2112291526.USD","LU2471134796.USD","LU2491049909.HKD","LU0238689110.USD","LU1127390331.HKD","LU0234572021.USD","LU2168564065.EUR","LU2357305700.SGD","LU0640476718.USD","LU1035775433.USD","LU1712237335.SGD","LU2264538146.SGD","LU2237438978.USD","BK4588","LU1868837136.USD","LU2462157665.USD","IE00BWXC8680.SGD","ABVX","LU2602419157.SGD","IE00BK4W5L77.USD","IE00B7KXQ091.USD","SG9999015978.USD","IE00BJJMRY28.SGD","IE00BJT1NW94.SGD","LU0094547139.USD","LU1551013425.SGD","SG9999018857.SGD","LU1814569148.SGD","LU2471134523.USD","LU0316494557.USD","IE00BJJMRX11.SGD","LU2237443895.HKD","LU0385154629.USD","IE00BFSS8Q28.SGD","LU2324357040.USD","BK4585","LU1989771016.USD","BK4599","LU1974910355.USD","IE00BJLML261.HKD","LU0432979614.USD","LU0289739699.SGD","BK4581","LU1623119135.USD","SG9999014914.USD","IE00BJJMRZ35.SGD","IE00BK4W5M84.HKD","LU2237443622.USD","LU2168564149.EUR","LU2552382215.SGD","LU0109394709.USD","LU2108987350.USD","LU1061106388.HKD","LU1069344957.HKD","LU0122379950.USD","SG9999014898.SGD","LU2168564495.EUR","SG9999014906.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU0203201768.USD","SG9999013999.USD","LU0471298694.HKD","LU2089984988.USD","LU1291159041.SGD","LU0256863902.USD","LU1804176565.USD","LU2456880835.USD","LU0097036916.USD","LU2417539215.USD","LU0882574055.USD","SG9999015986.USD","LU0882574139.USD","LU2468319806.SGD","LU1720051017.SGD","BK4007","LU2471134879.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603689858","title":"Abivax盘中异动 快速上涨8.71%报124.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603689858?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:31","pubTimestamp":1768228294,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时31分，Abivax股票出现异动，股价急速拉升8.71%。截至发稿，该股报124.37美元/股，成交量192.871万股，换手率2.46%，振幅4.35%。机构评级方面，在所有14家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Abivax股票所在的生物技术行业中，整体跌幅为0.64%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223134a4bb0ea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223134a4bb0ea3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187306954","title":"盘前｜ABVX暴涨27%，金银概念拉升，中概股普涨金山云升逾15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187306954","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187306954?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:11","pubTimestamp":1768219905,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段集体走低。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a5072cfb1070d2a2fa1cf0d5a3e836f5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX","CRML","KC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1144072941","title":"盘前异动｜ABVX、CRML暴涨，金银概念拉升，金山云涨逾14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144072941","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144072941?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:11","pubTimestamp":1768209082,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段集体走低。","market":"us","thumbnail":"https://static.tigerbbs.com/3a33c23f8e5a366189f532d19af270ed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3a33c23f8e5a366189f532d19af270ed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d8e3bd0478d779f273e2d3bf0b4908d3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX","CRML"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112862642","title":"礼来拟以150亿欧元收购法国生物制药公司Abivax S.A.","url":"https://stock-news.laohu8.com/highlight/detail?id=1112862642","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112862642?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:21","pubTimestamp":1768206095,"startTime":"0","endTime":"0","summary":"礼来 拟以150亿欧元收购该公司。","market":"us","thumbnail":"https://static.tigerbbs.com/69ae651cec94125693319268da981956","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/69ae651cec94125693319268da981956"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"39a7301965ab01d816c3e8bce60334df","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602592596","title":"法国生物制药公司ABIVAX股价在巴黎证券交易所出现大幅上涨，盘中最大涨幅达到27%。消息面上，礼来拟以150亿欧元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2602592596","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602592596?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:17","pubTimestamp":1768205840,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"39a7301965ab01d816c3e8bce60334df","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B4R5TH58.HKD","IE00BKDWB100.SGD","IE00B1BXHZ80.USD","LU1323610961.USD","LU2417539215.USD","IE00BJJMRX11.SGD","SG9999014880.SGD","LU2023250504.SGD","LU2471134879.HKD","LU2491050071.SGD","IE00B7KXQ091.USD","SG9999015945.SGD","LU0823434740.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU2471134523.USD","LU0889565916.HKD","SG9999015978.USD","LU0417517546.SGD","LU0471298777.SGD","SGXZ99366536.SGD","LU2168564065.EUR","LU0320765059.SGD","LU2491050154.USD","SGXZ81514606.USD","LU0234572021.USD","LU1127390331.HKD","LU2750360641.GBP","LU0820561818.USD","LU0432979614.USD","LU0256863902.USD","LU2087625088.SGD","IE00BJJMRZ35.SGD","LU2168564222.USD","LU2264538146.SGD","LU0943347566.SGD","SG9999015952.SGD","LU0316494557.USD","LU0689472784.USD","BK4588","LU1720051108.HKD","LU2360106947.USD","LU2552382132.HKD","LU1804176565.USD","LU0820561909.HKD","IE00BFSS7M15.SGD","BK4007","LU1093756325.SGD","LU1291159041.SGD","LU1868836914.USD","BK4581","IE00B4JS1V06.HKD","LU2089984988.USD","IE00BKPKM429.USD","LU1720051017.SGD","LU2361044865.SGD","LU2168563687.JPY","SGXZ51526630.SGD","LU2361045086.USD","LU2746668974.SGD","LU0106261372.USD","LU1057294990.SGD","LU2106854487.HKD","LU1712237335.SGD","LU2471134796.USD","SG9999013999.USD","LU1551013342.USD","LU0256863811.USD","LU0823416689.USD","LU2461242641.AUD","IE00BK4W5M84.HKD","IE0002141913.USD","LU0238689110.USD","BK4599","LU1023059063.AUD","LU0203201768.USD","LU1983299246.USD","LU0058720904.USD","LU2168564495.EUR","SG9999014914.USD","LU1989771016.USD","EUO","LU1548497426.USD","LU2491049909.HKD","IE00B775H168.HKD","LU0640476718.USD","LU0787776722.HKD","LU0823434583.USD","LU0353189763.USD","LU2746668461.USD","LU0385154629.USD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU2357305700.SGD","GB00BDT5M118.USD","LU0094547139.USD","LU0456855351.SGD","LU0354030438.USD","IE00BWXC8680.SGD","LU2265009873.SGD","LU1974910355.USD","LU2237443978.SGD","IE00BN29S564.USD","LU2237443622.USD","IE00BFSS8Q28.SGD","LU1035775433.USD","BK4533","BK4516","BK4585","LU2168564149.EUR","LU2471134952.CNY","IE00B1XK9C88.USD","SG9999014898.SGD","LU2108987350.USD","LU2237443382.USD","IE00BJLML261.HKD","LU0354030511.USD","SG9999018857.SGD","LU2237443895.HKD","LU1232071149.USD","LU0786609619.USD","IE00B2B36J28.USD","LU0683600562.USD","LU2237438978.USD","LU1093756168.USD","IE0005OL40V9.USD","LU0096364046.USD","LU2237443465.HKD","BK4534","LU0114720955.EUR","LU0471298694.HKD","LU1280957306.USD","SG9999017495.SGD","LU2552382215.SGD","SGXZ31699556.SGD","LU1069344957.HKD","LU2211815571.USD","LU1814569148.SGD","LU2236285917.USD","IE0004445239.USD","LU1267930730.SGD","LU1868837300.USD","ABVX","LU0708995401.HKD","LU2552382058.USD","LU1868837136.USD","SG9999014906.USD","LU1064131342.USD","LU2063271972.USD","LU2324357040.USD","LU0353189680.USD","LU0323591593.USD","LU0672654240.SGD","LU1868836591.USD","FXE","LU0061475181.USD","IE0009355771.USD","LU2602419157.SGD","LU0079474960.USD","LU1868836757.USD","LU2462157665.USD","LU0097036916.USD","SG9999015986.USD","LU0122379950.USD","LU0198837287.USD","LU0466842654.USD","LU2361044949.HKD","LU0266013472.USD","LU0225283273.USD","LU0109394709.USD","LU2237443549.SGD","LU1061106388.HKD","LU1988902786.USD","LU0289739699.SGD","IE00BK4W5L77.USD","LU0006306889.USD","LU0320765992.SGD","LU2750360997.AUD","LU0882574139.USD","LU2456880835.USD","LU2468319806.SGD","SG9999001176.USD","SG9999001176.SGD","IE0004445015.USD","LU0109391861.USD","LU1366192091.USD","IE00BJJMRY28.SGD","LU1917777945.USD","LU2112291526.USD","LU0203202063.USD","SG9999018865.SGD","SGXZ57979304.SGD","LU1623119135.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602394508","title":"Abivax盘中异动 股价大跌5.04%报120.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602394508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602394508?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:38","pubTimestamp":1767883095,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日22时38分，Abivax股票出现异动，股价快速下挫5.04%。截至发稿，该股报120.10美元/股，成交量11.9144万股，换手率0.15%，振幅3.61%。Abivax股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Century Therapeutics, Inc.、Enliven Therapeutics, Inc.、Moonlake Immunotherapeutics涨幅较大，Acrivon Therapeutics, Inc.、Gri Bio, Inc.、Moonlake Immunotherapeutics较为活跃，换手率分别为87.64%、52.41%、17.60%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Acrivon Therapeutics, Inc.、Moonlake Immunotherapeutics，振幅分别为33.87%、24.41%、23.74%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108223815a70377c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108223815a70377c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595202266","title":"看好核心药物obefazimod前景 投行古根海姆给予Abivax(ABVX.US)“买入“评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2595202266","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595202266?lang=zh_cn&edition=full","pubTime":"2025-12-29 14:55","pubTimestamp":1766991310,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在法国生物科技公司Abivax公布其核心药物obefazimod数据前，投行古根海姆公司将该公司的目标股价从150美元上调至175美元，并给予\"买入\"评级。分析师Yatin Suneja表示，做出此调整是基于对其核心药物obefazimod在第44周维持期数据读出的乐观前景。12月15日，Abivax公布了2025年第三季度财务业绩。然而，该季度每股亏损总计1.68美元。公司的财务活动反映出其正更加聚焦于其主要候选药物、同类首创口服miR-124增强剂obefazimod。Abivax正在为2026年的几个重要里程碑做准备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593435978","title":"美股异动 | 获礼来收购预期升温 Abivax(ABVX.US)开盘大涨逼近历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2593435978","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593435978?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:38","pubTimestamp":1766414309,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，Abivax S.A.(ABVX.US)开盘大涨近15%，逼近此前历史新高，现报131.59美元。消息面上，据报道，礼来公司已与法国当局展开初步讨论，以探索可能收购生物技术公司Abivax的事宜。报道称，礼来在12月初与法国财政部进行了初步会谈，以评估收购Abivax是否会受到该国外资投资审查规则的限制。根据报道，礼来还讨论了国有投资者Bpifrance作为少数股东可能参与的情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BWXC8680.SGD","LU1623119135.USD","LU1035775433.USD","LU2461242641.AUD","SGXZ57979304.SGD","BK4599","LU2471134796.USD","LU2491050071.SGD","LU0882574055.USD","IE00BJLML261.HKD","SG9999018857.SGD","LU0354030438.USD","LU0061475181.USD","LU0289739699.SGD","LU2168563687.JPY","LU0114720955.EUR","LU2023250504.SGD","LU1366192091.USD","LU2746668974.SGD","LU1280957306.USD","SG9999017495.SGD","LU1232071149.USD","IE0002141913.USD","LU2552382058.USD","LU0198837287.USD","LU1988902786.USD","LU0823416689.USD","LU0256863811.USD","LU0787776722.HKD","IE00B7KXQ091.USD","SGXZ51526630.SGD","BK4139","LU0203201768.USD","LU2237443549.SGD","BK4533","LU1323610961.USD","SG9999014906.USD","IE0004445239.USD","IE0004445015.USD","LU0471298777.SGD","LU2265009873.SGD","LU2264538146.SGD","ABVX","LU0320765059.SGD","LU2106854487.HKD","LU2417539215.USD","IE00B4R5TH58.HKD","LU0079474960.USD","LU1127390331.HKD","LU2361045086.USD","BK4516","BK4534","LU2211815571.USD","SG9999015945.SGD","LU2168564222.USD","LU1868836757.USD","LU0238689110.USD","LU1720051017.SGD","LU0094547139.USD","LU1551013342.USD","LU2112291526.USD","LU2237443622.USD","LU1548497426.USD","LU1551013425.SGD","LU2456880835.USD","LU0943347566.SGD","LU0456855351.SGD","IE00BN29S564.USD","IE0005OL40V9.USD","LU0889565916.HKD","LU0823434583.USD","LU2237443382.USD","IE00B1BXHZ80.USD","LU0256863902.USD","LU1983299246.USD","LU2462157665.USD","LU2491049909.HKD","GB00BDT5M118.USD","LU0471298694.HKD","LU0786609619.USD","LU0203202063.USD","LU0640476718.USD","LU0882574139.USD","LU2361044949.HKD","LU0353189680.USD","LU0109394709.USD","LU0708995401.HKD","LU0820561818.USD","LU1064131342.USD","LU1974910355.USD","LU2087625088.SGD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2108987350.USD","IE00B1XK9C88.USD","LU2552382132.HKD","LU2746668461.USD","LU2237443895.HKD","SG9999014880.SGD","LU2552382215.SGD","LU1291159041.SGD","LU1814569148.SGD","BK4007","LU1069344957.HKD","LU2063271972.USD","LU1093756325.SGD","LU2089984988.USD","LU0823434740.USD","LU1267930730.SGD","IE00BFSS8Q28.SGD","LU2602419157.SGD","LU0354030511.USD","LU0122379950.USD","LU2357305700.SGD","LU2360106947.USD","LU0385154629.USD","LU2237443465.HKD","IE00BK4W5L77.USD","LU0096364046.USD","IE00B4JS1V06.HKD","SGXZ31699556.SGD","IE00BJJMRX11.SGD","LU0320765992.SGD","LU0417517546.SGD","SG9999001176.USD","LU0353189763.USD","LU1868836591.USD","LU1868837300.USD","LU0006306889.USD","LU2237438978.USD","BK4585","LU0689472784.USD","LU0323591593.USD","LU0432979614.USD","SG9999018865.SGD","LU2491050154.USD","LU0097036916.USD","LU1917777945.USD","LU1057294990.SGD","LU1061106388.HKD","SGXZ81514606.USD","SG9999014914.USD","IE00B2B36J28.USD","SG9999015986.USD","LU0466842654.USD","SGXZ99366536.SGD","IE00BFTCPJ56.SGD","LU0683600562.USD","IE00B775H168.HKD","LU2361044865.SGD","IE0009355771.USD","LU0820561909.HKD","IE00BKDWB100.SGD","LU2236285917.USD","LU2468319806.SGD","BK4588","SG9999013999.USD","LU1989771016.USD","SG9999014898.SGD","LU1720051108.HKD","LU1712237335.SGD","LU2237443978.SGD","LU0109391861.USD","LU2168564495.EUR","IE00BJT1NW94.SGD","LU1093756168.USD","LU2471134879.HKD","SG9999001176.SGD","LU2471134952.CNY","BK4581","LU0316494557.USD","IE00BJJMRY28.SGD","LU2324357040.USD","IE00BFSS7M15.SGD","IE00BKPKM429.USD","LU0266013472.USD","LU0234572021.USD","LU0672654240.SGD","SG9999015952.SGD","LU1804176565.USD","LU2750360641.GBP","LU1868836914.USD","LU1023059063.AUD","LU0106261372.USD","LU2168564065.EUR","LU2168564149.EUR","LU0058720904.USD","SG9999015978.USD","LU1868837136.USD","LU2471134523.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155516283","title":"盘前｜英伟达快速拉升，CoreWeave续涨3%，ABVX大涨17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155516283","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155516283?lang=zh_cn&edition=full","pubTime":"2025-12-22 20:17","pubTimestamp":1766405831,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段集体上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX","CRWV","NVDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593481161","title":"礼来据悉可能收购法国生物技术公司Abivax","url":"https://stock-news.laohu8.com/highlight/detail?id=2593481161","media":"市场资讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593481161?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:56","pubTimestamp":1766397360,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ （来源：界面新闻）12月22日消息，据报道，礼来可能收购法国生物技术公司Abivax。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-12-22/doc-inhcsmfc4530208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999001176.USD","IE00B1BXHZ80.USD","LU2168564222.USD","LU2471134952.CNY","LU1868836757.USD","LU2106854487.HKD","SG9999013999.USD","LU2750360997.AUD","SG9999014906.USD","LU2746668974.SGD","LU0354030438.USD","LU1983299246.USD","LU0203201768.USD","IE00BK4W5M84.HKD","IE00BJJMRZ35.SGD","LU2357305700.SGD","LU0823434740.USD","IE0004445015.USD","LU0109391861.USD","LU0320765992.SGD","LU1720051017.SGD","LU2324357040.USD","BK4581","LU1868836591.USD","LU2237438978.USD","BK4599","LU0289739699.SGD","SGXZ31699556.SGD","LU0672654240.SGD","LU2168564495.EUR","LU0096364046.USD","LU0238689110.USD","BK4588","LLY","LU1868836914.USD","LU0006306889.USD","LU0820561909.HKD","LU2552382058.USD","LU1023059063.AUD","IE00B2B36J28.USD","LU0320765059.SGD","LU1814569148.SGD","LU1720051108.HKD","LU1917777945.USD","SGXZ99366536.SGD","SG9999014914.USD","LU0417517546.SGD","LU0432979614.USD","LU2168564065.EUR","LU0203202063.USD","SG9999014880.SGD","LU1868837300.USD","LU2746668461.USD","IE00B4JS1V06.HKD","LU1974910355.USD","LU1064131342.USD","IE00BKDWB100.SGD","LU0471298777.SGD","LU0708995401.HKD","LU1280957306.USD","IE0005OL40V9.USD","IE00BKPKM429.USD","LU2168564149.EUR","LU1804176565.USD","BK4534","LU0079474960.USD","LU1093756168.USD","LU1868837136.USD","IE00B7KXQ091.USD","SG9999015952.SGD","LU2265009873.SGD","SG9999017495.SGD","LU0823416689.USD","SGXZ57979304.SGD","IE00BFSS7M15.SGD","LU1093756325.SGD","IE00B775H168.HKD","LU2552382132.HKD","LU0122379950.USD","LU2456880835.USD","LU1988902786.USD","LU1548497426.USD","LU1989771016.USD","IE00BJJMRX11.SGD","LU2491049909.HKD","BK4533","LU1623119135.USD","LU2236285917.USD","LU2112291526.USD","LU2417539215.USD","LU0353189763.USD","LU0456855351.SGD","BK4516","LU0114720955.EUR","SG9999014898.SGD","LU2361044949.HKD","LU2750360641.GBP","LU0820561818.USD","LU0266013472.USD","IE00BN29S564.USD","LU0109394709.USD","LU0889565916.HKD","LU2237443622.USD","ABVX","SG9999018865.SGD","IE00B1XK9C88.USD","GB00BDT5M118.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0256863902.USD","LU1035775433.USD","LU2361045086.USD","SG9999015945.SGD","LU2468319806.SGD","LU1291159041.SGD","LU2168563687.JPY","LU2264538146.SGD","LU2462157665.USD","LU1057294990.SGD","LU0823434583.USD","LU2023250504.SGD","LU2237443549.SGD","SG9999015986.USD","LU0198837287.USD","LU0058720904.USD","BK4007","LU2063271972.USD","IE00B4R5TH58.HKD","LU0466842654.USD","LU0234572021.USD","LU2360106947.USD","LU2491050071.SGD","LU2552382215.SGD","LU1323610961.USD","LU0094547139.USD","LU2491050154.USD","SG9999018857.SGD","BK4585","LU0640476718.USD","LU1551013342.USD","LU1232071149.USD","LU0786609619.USD","IE00BJLML261.HKD","IE00BFSS8Q28.SGD","SGXZ51526630.SGD","IE0002141913.USD","LU0097036916.USD","LU2471134796.USD","LU0943347566.SGD","LU1127390331.HKD","SGXZ81514606.USD","LU2087625088.SGD","LU0106261372.USD","LU1366192091.USD","LU1267930730.SGD","LU0471298694.HKD","IE00BK4W5L77.USD","IE00BWXC8680.SGD","LU0882574139.USD","LU2237443895.HKD","LU2361044865.SGD","LU2211815571.USD","LU2602419157.SGD","SG9999001176.SGD","LU1712237335.SGD","LU0385154629.USD","IE0004445239.USD","LU0323591593.USD","LU1069344957.HKD","LU0353189680.USD","LU1551013425.SGD","IE00BJJMRY28.SGD","LU0316494557.USD","LU2471134523.USD","LU2108987350.USD","LU0256863811.USD","LU0787776722.HKD","LU2237443465.HKD","LU2237443978.SGD","LU2471134879.HKD","LU0689472784.USD","LU2237443382.USD","LU2461242641.AUD","LU2089984988.USD","LU0683600562.USD","SG9999015978.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU0061475181.USD","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abivax.com","stockEarnings":[{"period":"1week","weight":0.0441},{"period":"1month","weight":0.1787},{"period":"3month","weight":0.0678},{"period":"6month","weight":0.0374},{"period":"1year","weight":21.7993},{"period":"ytd","weight":-0.0397}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0603},{"period":"3month","weight":0.1},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2839},{"period":"ytd","weight":0.1066}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Abivax Sa是一家于2013年12月4日根据法国法律注册成立。该公司是一家临床阶段的生物技术公司，专注于开发利用人体自然调节机制来稳定慢性炎症性疾病免疫反应的疗法。其主要候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段，并正在开发用于克罗恩病。","exchange":"NASDAQ","name":"Abivax S.A.","nameEN":"Abivax S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Abivax S.A.(ABVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Abivax S.A.,ABVX,Abivax S.A.股票,Abivax S.A.股票老虎,Abivax S.A.股票老虎国际,Abivax S.A.行情,Abivax S.A.股票行情,Abivax S.A.股价,Abivax S.A.股市,Abivax S.A.股票价格,Abivax S.A.股票交易,Abivax S.A.股票购买,Abivax S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Abivax S.A.(ABVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}